Original Source(s)
Related Content
Mavacamten Treatment Associated With Improved Diastolic Function, Remodeling Markers
Real-world follow-up data from 465 patients add to evidence from earlier randomized trials.
June 27, 2026
-
3 min
Diabetes Risk Scores: Beyond Glucose
Multi-ancestry polygenic models identify high-risk patients traditional screening may miss.
May 13, 2026
-
5 min
FDA Approves First Oral PCSK9 Inhibitor
Merck reported placebo-adjusted LDL-C reductions of 56% and 59% at week 24 in two phase 3 CORALreef trials supporting the approval.
July 16, 2026
-
2 min